Remus Pharmaceuticals Limited
Bookbuilding IPO · NSE
- Price band
- ₹1150 - ₹1229
- Lot size
- 100 shares
- Issue amount
- ₹47.69 cr
- Total subscription
- 61.53×
- Opens
- 17 May 2023
- Closes
- 19 May 2023
- Allotment
- 24 May 2023
- Listing
- 29 May 2023
Offer at a glance
Issue overview
- Issue size
- 3,88,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,15,000
- Fresh issue
- ₹47.69 cr
- Offer for sale
- ₹0 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,22,900
- Issue type
- Bookbuilding IPO
- Shares before issue
- 10,85,000
- Shares after issue
- 14,73,000
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 100 | ₹1,22,900 |
| HNI | 2 | 200 | ₹2,45,800 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 9.06 | 183.37 |
| RETAIL | 15.85 | 594.54 |
| NIB | 6.8 | 1,173.08 |
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Key performance indicators
| Metric | Values |
|---|---|
| EPS | 33.86 |
| ROE | 71.44 |
| ROCE | 69.99 |
| RONW | 52.64 |
| PRE IPO(PE) | 21.09 |
| POST IPO(PE) | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Incorporated in 2015, Remus Pharmaceuticals Limited is engaged in the marketing and distribution of pharmaceutical products, including Active Pharmaceutical Ingredients (APIs) and finished formulations in various dosage forms. As of January 31, 2023, the company offers 429 products, with 295 registered in 13 countries and 134 under registration in 16 countries. Remus Pharmaceuticals maintains business-to-business agreements with 58 domestic and 139 international distributors, serving clients across more than 20 countries, including generic distributors, regional distributors, multinational distributors, hospitals, and clinics.
Promoters
Mr. Arpit Deepakkumar Shah
Ms. Roma Vinodbhai Shah
Mr. Swapnil Jatinbhai Shah
Mrs. Anar Swapnil Shah
Registrar & documents
Lead manager
Beeline Capital Advisors Private Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
1101 to 1103, South Tower, One 42, B/H Ashok Vatika, Nr. Jayantilal Park BRTS, Ambli bopal Road, Ahmedabad - 380054
+079- 2999 9857
[email protected]Company website ↗Frequently Asked Questions
What is Remus Pharmaceuticals IPO GMP today?
As of today, Remus Pharmaceuticals IPO Grey Market Premium (GMP) is reported at +₹470 per share. Based on the upper price band of ₹1,229, the estimated listing price is ₹1,699 (+38.2% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Remus Pharmaceuticals IPO?
The minimum bid lot size for Remus Pharmaceuticals IPO is 100 shares. At the cut-off price of ₹1,229 per share, retail investors need a minimum application amount of ₹1,22,900 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).
When will Remus Pharmaceuticals IPO allotment status be announced?
The allotment status for Remus Pharmaceuticals IPO is scheduled to be finalized on 24 May 2023. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Link Intime India Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Remus Pharmaceuticals IPO allotment status online by PAN?
To check Remus Pharmaceuticals IPO allotment status: 1) Visit the registrar portal (Link Intime India Private Limited) or the BSE IPO allotment page. 2) Select 'Remus Pharmaceuticals Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.